Free Trial

Abbott Laboratories (ABT) News Today

$107.58
+3.31 (+3.17%)
(As of 06/7/2024 ET)
Schroder Investment Management Group Has $105.24 Million Stake in Abbott Laboratories (NYSE:ABT)
Schroder Investment Management Group trimmed its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 9.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 956,134 shares of the h
Abbott Laboratories (NYSE:ABT) Stock Price Up 3.4%
Abbott Laboratories (NYSE:ABT) Stock Price Up 3.4%
Pinebridge Investments L.P. Lowers Stake in Abbott Laboratories (NYSE:ABT)
Pinebridge Investments L.P. reduced its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 20.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 295,950 shares of the healthcare produc
Cibc World Markets Corp Cuts Position in Abbott Laboratories (NYSE:ABT)
Cibc World Markets Corp trimmed its position in Abbott Laboratories (NYSE:ABT - Free Report) by 36.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 223,366 shares of the healthcare product maker's
Rhenman & Partners Asset Management AB Sells 56,675 Shares of Abbott Laboratories (NYSE:ABT)
Rhenman & Partners Asset Management AB decreased its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 21.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 205,000 s
Abbott Laboratories (NYSE:ABT) Given Outperform Rating at Royal Bank of Canada
Royal Bank of Canada restated an "outperform" rating and set a $125.00 price objective on shares of Abbott Laboratories in a report on Tuesday.
CIBC Private Wealth Group LLC Has $546.17 Million Position in Abbott Laboratories (NYSE:ABT)
CIBC Private Wealth Group LLC trimmed its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 0.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,962,011 shares of the healthcare product maker's
Abbott Laboratories (NYSE:ABT) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of Abbott Laboratories (NYSE:ABT - Get Free Report) have received an average rating of "Moderate Buy" from the ten brokerages that are currently covering the company, MarketBeat reports. Three analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendat
Eagle Asset Management Inc. Trims Stock Holdings in Abbott Laboratories (NYSE:ABT)
Eagle Asset Management Inc. reduced its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 3.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 933,527 shares of the healthcare product maker's stock after s
Abbott Laboratories (NYSE:ABT) Stock Position Decreased by Alberta Investment Management Corp
Alberta Investment Management Corp cut its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 70.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 51,500 shares of the healthcare product maker's stock afte
TFO Wealth Partners LLC Buys 8,142 Shares of Abbott Laboratories (NYSE:ABT)
TFO Wealth Partners LLC boosted its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 2,035.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 8,542 shares of the healthcare product maker's stock af
Abbott Laboratories (NYSE:ABT) Earns Buy Rating from Analysts at The Goldman Sachs Group
The Goldman Sachs Group initiated coverage on Abbott Laboratories in a report on Thursday. They issued a "buy" rating and a $121.00 price objective on the stock.
Greg Abbott Gets New Ally in Texas
TD Asset Management Inc Has $145.49 Million Stake in Abbott Laboratories (NYSE:ABT)
TD Asset Management Inc reduced its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 36.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,321,757 shares of the healthcare product
Abbott Laboratories (NYSE:ABT) Position Lessened by Bruce & Co. Inc.
Bruce & Co. Inc. reduced its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 6.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 150,000 shares of the healthcare product maker's stock after selling
Abbott Laboratories (NYSE:ABT) Shares Bought by United Services Automobile Association
United Services Automobile Association increased its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 110.4% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 97,678 shares of the healthcare product maker's stoc
TCW Group Inc. Acquires New Stake in Abbott Laboratories (NYSE:ABT)
TCW Group Inc. bought a new stake in Abbott Laboratories (NYSE:ABT - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The fund bought 28,267 shares of the healthcare product maker's stock, valued at approximately $3,120,000. Several other hedge funds have also
Abbott Laboratories (NYSE:ABT) Shares Sold by Primecap Management Co. CA
Primecap Management Co. CA lessened its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 2.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,858,141 shares of the health
Abbott Laboratories (NYSE:ABT) Shares Bought by Cambridge Investment Research Advisors Inc.
Cambridge Investment Research Advisors Inc. boosted its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 8.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 299,242 shares of the healt
Frazier Financial Advisors LLC Takes $3.68 Million Position in Abbott Laboratories (NYSE:ABT)
Frazier Financial Advisors LLC acquired a new stake in Abbott Laboratories (NYSE:ABT - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 33,414 shares of the healthcare product maker's
Oxler Private Wealth LLC Buys 10,454 Shares of Abbott Laboratories (NYSE:ABT)
Oxler Private Wealth LLC lifted its position in Abbott Laboratories (NYSE:ABT - Free Report) by 141.3% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 17,851 shares of the healthcare product maker's stock
Abbott Laboratories (NYSE:ABT) Stock Holdings Increased by Franklin Resources Inc.
Franklin Resources Inc. raised its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 1.6% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 8,316,700 shares of the healthcare product maker's stock after buying an additional 1
Abbott Laboratories (NYSE:ABT) Shares Sold by ING Groep NV
ING Groep NV cut its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 71.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 272,681 shares of the healthcare product maker's stock
Abbott Laboratories (NYSE:ABT) is Great Lakes Advisors LLC's 7th Largest Position
Great Lakes Advisors LLC lowered its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 14.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,121,309 shares of the healthcare product maker's stock after selling
Fairhaven Wealth Management LLC Acquires 10,495 Shares of Abbott Laboratories (NYSE:ABT)
Fairhaven Wealth Management LLC grew its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 196.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 15,834 shares of the healthcare product maker's
Lmcg Investments LLC Boosts Position in Abbott Laboratories (NYSE:ABT)
Lmcg Investments LLC lifted its position in Abbott Laboratories (NYSE:ABT - Free Report) by 15.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 149,847 shares of the healthcare pr
Get Abbott Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter.

After Conviction, More Bad News for Trump (Ad)

As a former advisor to the CIA, the Pentagon and the White House… I feel it’s my duty to warn you about this coming election meltdown.

Click here to see the details because this coming election meltdown could trigger…

ABT Media Mentions By Week

ABT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ABT
News Sentiment

0.96

0.73

Average
Medical
News Sentiment

ABT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ABT Articles
This Week

16

17

ABT Articles
Average Week

Get Abbott Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NYSE:ABT) was last updated on 6/8/2024 by MarketBeat.com Staff

From Our Partners